ClinicalTrials.govpublic full text
Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
oral cavity squamous cell carcinoma, oral squamous cell carcinoma, oropharyngeal squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846561
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.